249 related articles for article (PubMed ID: 1418319)
1. Conformation-dependent accessibility of the linear epitopes located on the rabies virus glycoprotein.
Kontsekova E; Macikova I; Novak M; Dedek L; Vrzal V; Kontsek P
Viral Immunol; 1992; 5(3):213-20. PubMed ID: 1418319
[TBL] [Abstract][Full Text] [Related]
2. Common and different antigenic properties of the rabies virus glycoprotein of strains SAD-Vnukovo and Pitman-Moore.
Máciková I; Dedek L; Vrzal V; Kontseková E; Kontsek P; Ciampor F; Novák M
Acta Virol; 1992 Dec; 36(6):541-50. PubMed ID: 1284868
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a new virus-neutralizing epitope that denotes a sequential determinant on the rabies virus glycoprotein.
Bunschoten H; Gore M; Claassen IJ; Uytdehaag FG; Dietzschold B; Wunner WH; Osterhaus AD
J Gen Virol; 1989 Feb; 70 ( Pt 2)():291-8. PubMed ID: 2471786
[TBL] [Abstract][Full Text] [Related]
4. Antigenic and functional analyses of glycoprotein of rabies virus using monoclonal antibodies.
Luo TR; Minamoto N; Hishida M; Yamamoto K; Fujise T; Hiraga S; Ito N; Sugiyama M; Kinjo T
Microbiol Immunol; 1998; 42(3):187-93. PubMed ID: 9570284
[TBL] [Abstract][Full Text] [Related]
5. Immunodominant epitopes defined by a yeast-expressed library of random fragments of the rabies virus glycoprotein map outside major antigenic sites.
Lafay F; Benmansour A; Chebli K; Flamand A
J Gen Virol; 1996 Feb; 77 ( Pt 2 )():339-46. PubMed ID: 8627238
[TBL] [Abstract][Full Text] [Related]
6. Mapping and characterization of a sequential epitope on the rabies virus glycoprotein which is recognized by a neutralizing monoclonal antibody, RG719.
Ni Y; Tominaga Y; Honda Y; Morimoto K; Sakamoto S; Kawai A
Microbiol Immunol; 1995; 39(9):693-702. PubMed ID: 8577283
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies which recognize the acidic configuration of the rabies glycoprotein at the surface of the virion can be neutralizing.
Raux H; Coulon P; Lafay F; Flamand A
Virology; 1995 Jul; 210(2):400-8. PubMed ID: 7542418
[TBL] [Abstract][Full Text] [Related]
8. Novel monoclonal antibodies that bind to wild and fixed rabies virus strains.
Zanluca C; Aires LR; Mueller PP; Santos VV; Carrieri ML; Pinto AR; Zanetti CR
J Virol Methods; 2011 Jul; 175(1):66-73. PubMed ID: 21536074
[TBL] [Abstract][Full Text] [Related]
9. Use of hybridoma monoclonal antibodies in the detection of antigenic differences between rabies and rabies-related virus proteins. II. The glycoprotein.
Flamand A; Wiktor TJ; Koprowski H
J Gen Virol; 1980 May; 48(1):105-9. PubMed ID: 6155432
[TBL] [Abstract][Full Text] [Related]
10. Characterization of epitopes on the rabies virus glycoprotein by selection and analysis of escape mutants.
Fallahi F; Wandeler AI; Nadin-Davis SA
Virus Res; 2016 Jul; 220():161-71. PubMed ID: 27132040
[TBL] [Abstract][Full Text] [Related]
11. Structural and functional studies on a unique linear neutralizing antigenic site (G5) of the rabies virus glycoprotein.
van der Heijden RW; Langedijk JP; Groen J; UytdeHaag FG; Meloen RH; Osterhaus AD
J Gen Virol; 1993 Aug; 74 ( Pt 8)():1539-45. PubMed ID: 7688410
[TBL] [Abstract][Full Text] [Related]
12. Antigenic analysis of equine infectious anemia virus (EIAV) variants by using monoclonal antibodies: epitopes of glycoprotein gp90 of EIAV stimulate neutralizing antibodies.
Hussain KA; Issel CJ; Schnorr KL; Rwambo PM; Montelaro RC
J Virol; 1987 Oct; 61(10):2956-61. PubMed ID: 2442410
[TBL] [Abstract][Full Text] [Related]
13. Use of anti-glycoprotein monoclonal antibodies to characterize rabies virus in formalin-fixed tissues.
Warner C; Fekadu M; Whitfield S; Shaddock J
J Virol Methods; 1999 Jan; 77(1):69-74. PubMed ID: 10029326
[TBL] [Abstract][Full Text] [Related]
14. Antigenic structure of the E2 glycoprotein from transmissible gastroenteritis coronavirus.
Correa I; Jiménez G; Suñé C; Bullido MJ; Enjuanes L
Virus Res; 1988 Apr; 10(1):77-93. PubMed ID: 2453977
[TBL] [Abstract][Full Text] [Related]
15. Generation and characterization of human monoclonal antibodies to G5, a linear neutralization epitope on glycoprotein of rabies virus, by phage display technology.
Zhao XL; Yin J; Chen WQ; Jiang M; Yang G; Yang ZH
Microbiol Immunol; 2008 Feb; 52(2):89-93. PubMed ID: 18380806
[TBL] [Abstract][Full Text] [Related]
16. Glycoprotein B of Aujeszky's disease virus: topographical epitope mapping and epitope-specific antibody response.
Zaripov MM; Morenkov OS; Siklodi B; Barna-Vetro I; Gyöngyösi-Horvath A; Fodor I
Res Virol; 1998; 149(1):29-41. PubMed ID: 9561562
[TBL] [Abstract][Full Text] [Related]
17. Novel human monoclonal antibody combination effectively neutralizing natural rabies virus variants and individual in vitro escape mutants.
Bakker AB; Marissen WE; Kramer RA; Rice AB; Weldon WC; Niezgoda M; Hanlon CA; Thijsse S; Backus HH; de Kruif J; Dietzschold B; Rupprecht CE; Goudsmit J
J Virol; 2005 Jul; 79(14):9062-8. PubMed ID: 15994800
[TBL] [Abstract][Full Text] [Related]
18. Identification of rabies virus mimotopes screened from a phage display peptide library with purified dog anti-rabies virus serum IgG.
Yang L; Cen J; Xue Q; Li J; Bi Y; Sun L; Liu W
Virus Res; 2013 Jun; 174(1-2):47-51. PubMed ID: 23499997
[TBL] [Abstract][Full Text] [Related]
19. Development of human monoclonal antibodies to rabies.
Dorfman N; Dietzschold B; Kajiyama W; Fu ZF; Koprowski H; Notkins AL
Hybridoma; 1994 Oct; 13(5):397-402. PubMed ID: 7860096
[TBL] [Abstract][Full Text] [Related]
20. [Production of monoclonal antibodies against a wild strain of rabies virus].
Akacem O; Benmansour A; Coulon P; Brahimi M; Benhassine M
Arch Inst Pasteur Alger; 1992; 58():283-90. PubMed ID: 1309144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
